deferoxamine has been researched along with Salmonella Infections, Animal in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Salmonella Infections, Animal: Infections in animals with bacteria of the genus SALMONELLA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nairz, M | 2 |
| Schleicher, U | 1 |
| Schroll, A | 1 |
| Sonnweber, T | 1 |
| Theurl, I | 1 |
| Ludwiczek, S | 1 |
| Talasz, H | 1 |
| Brandacher, G | 1 |
| Moser, PL | 1 |
| Muckenthaler, MU | 1 |
| Fang, FC | 2 |
| Bogdan, C | 1 |
| Weiss, G | 2 |
| Fritsche, G | 1 |
| Libby, SJ | 1 |
| Kingsley, RA | 1 |
| Reissbrodt, R | 1 |
| Rabsch, W | 1 |
| Ketley, JM | 1 |
| Tsolis, RM | 1 |
| Everest, P | 1 |
| Dougan, G | 1 |
| Bäumler, AJ | 1 |
| Roberts, M | 1 |
| Williams, PH | 1 |
| Collins, HL | 1 |
| Kaufmann, SH | 1 |
| Schaible, UE | 1 |
| Jones, RL | 1 |
| Peterson, CM | 1 |
| Grady, RW | 1 |
| Kumbaraci, T | 1 |
| Cerami, A | 1 |
| Graziano, JH | 1 |
| Kramer, TT | 1 |
| Saucke, L | 1 |
| Griffith, RW | 1 |
| Kunesh, JP | 1 |
6 other studies available for deferoxamine and Salmonella Infections, Animal
| Article | Year |
|---|---|
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cation Transport Proteins; Deferoxa | 2013 |
Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression.
Topics: Acute-Phase Proteins; Animals; Cation Transport Proteins; Cell Line; Deferoxamine; Hydrogen Peroxide | 2012 |
Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica.
Topics: Amino Acid Sequence; Animals; Bacterial Outer Membrane Proteins; Base Sequence; Biological Transport | 1999 |
Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst.
Topics: Animals; Deferoxamine; Enzyme Inhibitors; Female; Injections, Intraperitoneal; Iron Chelating Agents | 2002 |
Effects of iron chelators and iron overload on Salmonella infection.
Topics: Animals; Deferoxamine; Hydroxybenzoates; Iron; Iron Chelating Agents; Male; Mice; Mutation; Salmonel | 1977 |
Desferoxamine and iron dextran in acute Salmonella cholerae-suis infection in pigs.
Topics: Acute Disease; Animals; Body Temperature; Deferoxamine; Drug Therapy, Combination; Erythrocyte Count | 1986 |